Not applicableNot Yet RecruitingNCT06603974What this trial is testingThe Efficacy and Safety of Benmelstobart for GC/EGCWho this might be right forGastric Cancer Xijing Hospital 48
Large-scale testing (Phase 3)Study completedNCT02625623What this trial is testingAvelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)Who this might be right forUnresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaGastric Cancer Third Line EMD Serono Research & Development Institute, Inc. 371
Post-approval studies (Phase 4)Not Yet RecruitingNCT07829757What this trial is testingZolbetuximab Given With mFOLFOX6 or CAPOX Chemotherapy in Indian Adults With Gastric CancerWho this might be right forLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerLocally Advanced Unresectable Gastric Adenocarcinoma or CancerMetastatic Gastric Adenocarcinoma or Cancer+1 more Astellas Pharma Global Development, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT04278144What this trial is testingA First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid TumorsWho this might be right forHER2-positive Solid TumorsHER2-positive Breast CancerHER2-positive Colorectal Cancer+2 more Bolt Biotherapeutics, Inc. 175
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07692334What this trial is testingBecotatugvedotin Plus Pucotenlimab in EGFR-Positive Advanced Gastric/GEJ AdenocarcinomaWho this might be right forGastric CancerGastroesophageal Junction (GEJ) AdenocarcinomaBecotatug Vedotin+1 more West China Second University Hospital 28
Testing effectiveness (Phase 2)Study completedNCT00183898What this trial is testingStudy of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction CancerWho this might be right forGastric CancerEsophageal Cancer University of Southern California 75
Testing effectiveness (Phase 2)Looking for participantsNCT07692204What this trial is testingA Dose Optimization/Expansion Study of SAR445877 in Adult Chinese Participants With Advanced Gastric or Gastroesophageal Junction CancerWho this might be right forGastric CancerOesophageal Carcinoma Sanofi 30
Early research (Phase 1)Study completedNCT01561014What this trial is testingOxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionWho this might be right forAdenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionAdenocarcinoma of the Stomach+5 more Wake Forest University Health Sciences 9
Large-scale testing (Phase 3)Active Not RecruitingNCT04704934What this trial is testingTrastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)Who this might be right forGastric Cancer, AdenocarcinomaGastroesophageal Junction Adenocarcinoma Daiichi Sankyo 490
Testing effectiveness (Phase 2)UnknownNCT03139487What this trial is testingPhase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous ThromboembolismWho this might be right forCancer-associated ThrombosisEsophageal CancerStomach Cancer+7 more Asan Medical Center 176
Early research (Phase 1)WithdrawnNCT06341647What this trial is testingPhase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201Who this might be right forBreast CancerGastric CancerGastroesophageal Junction Adenocarcinoma GC Cell Corporation
Testing effectiveness (Phase 2)Study completedNCT00062374What this trial is testingIrinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal JunctionWho this might be right forGastric AdenocarcinomaStage II Gastric CancerStage III Gastric Cancer+1 more National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Ended earlyNCT01307956What this trial is testingPanitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction CancerWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionEsophageal AdenocarcinomaStage IIA Esophageal Cancer+1 more University of Nebraska 11
Early research (Phase 1)Study completedNCT04772989What this trial is testingEvaluate AB308 in Combination With AB122 in Participants With Advanced MalignanciesWho this might be right forAdvanced Solid TumorNon Small Cell Lung Cancer (NSCLC)Melanoma+7 more Arcus Biosciences, Inc. 94
Testing effectiveness (Phase 2)Active Not RecruitingNCT04041310What this trial is testingNous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid TumorsWho this might be right forSolid Tumor, Adult Nouscom SRL 115
Not applicableStudy completedNCT05663450What this trial is testingExtended Resection After Positive Intraoperative Pathology in Gastric Cancer SurgeryWho this might be right forGastric Cancer University Hospital of Cologne 679
Not applicableLooking for participantsNCT04221893What this trial is testingRadiation Therapy for the Treatment of Metastatic Gastrointestinal CancersWho this might be right forStage IV Esophageal AdenocarcinomaStage IV Esophageal Squamous Cell CarcinomaStage IV Gastric Cancer+41 more University of California, San Francisco 28
Testing effectiveness (Phase 2)UnknownNCT02007148What this trial is testingMetronomIc CApecitabine and DOcetaxel as Second-line Chemotherapy for Advanced Gastric CancerWho this might be right forGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma International Group of Endovascular Oncology 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT02678182What this trial is testingPlanning Treatment for Oesophago-gastric Cancer: a Maintenance Therapy TrialWho this might be right forAdenocarcinoma of the OesophagusAdenocarcinoma of the Gastro-oesophageal JunctionAdenocarcinoma of the Stomach Royal Marsden NHS Foundation Trust 494
Testing effectiveness (Phase 2)Looking for participantsNCT05894824What this trial is testingT-Dxd in Combination With Ramucirumab as HER2 Low Gastric or Gastroesophageal Junction (GEJ) AdenocarcinomaWho this might be right forGastric CancerGastroesophageal Junction (GEJ) Cancer Yonsei University 58